Elicio Therapeutics, Inc. Common Stock

ELTX

Elicio Therapeutics, Inc. is a biotechnology company focused on developing immunotherapies that stimulate the body’s immune system to fight cancer. Their platform utilizes particulate vaccines designed to target and activate immune cells, aiming to improve the effectiveness of cancer treatments and address unmet medical needs in oncology.

$8.34 +0.34 (4.25%)
🚫 Elicio Therapeutics, Inc. Common Stock does not pay dividends

Company News

Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer
GlobeNewswire Inc. • Marc J. Wolfgang • November 19, 2025

Elicio Therapeutics appointed Marc J. Wolfgang as Chief Technology Officer, bringing over 30 years of biopharmaceutical leadership experience to strengthen the company's late-stage and commercial readiness for its immunotherapy pipeline.

BNTX
Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga • Avi Kapoor • January 3, 2024

Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods downgraded rating on the stock. Keefe, Bruyette & Woods analyst Michael Perito downgraded SoFi from a Market Perform rating to an Underperform rating and lowered the price target from $7.50 to $6.50, citing recent outperforman...

PRCHDYNAEVAIFBDESPRGOTU

Related Companies

Electro-Sensors Inc
Electro-Sensors Inc
ELSE
Eltek Ltd
Eltek Ltd
ELTK
Elevance Health, Inc.
Elevance Health, Inc.
ELV
Elutia Inc. Class A Common Stock
ELUT